Survivin: A promising biomarker for detection and prognosis of bladder cancer

World Journal of Urology

Volumn 26, Issue 1, 2008, Pages 59-65

  Margulis, Vitaly ^a   Lotan, Yair ^b   Shariat, Shahrokh F ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bladder cancer; Detection; Prognosis; Survivin; Target; Urine

Indexed keywords

BIRC5 PROTEIN, HUMAN; DNA; MICROTUBULE ASSOCIATED PROTEIN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; GENE EXPRESSION REGULATION; GENETICS; HEALTH; HUMAN; MASS SCREENING; METABOLISM; METHODOLOGY; MORBIDITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MASS SCREENING; MICROTUBULE-ASSOCIATED PROTEINS; MORBIDITY; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; WORLD HEALTH;

EID: 39349098773     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-007-0219-y     Document Type: Article

References (42)

1. Jemal A, Siegel R, Ward E et al (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43-66
2. Landman J, Chang Y, Kavaler E et al (1998) Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer. Urology 52:398-402
3. Lahme S, Bichler KH, Feil G et al (2003) Comparison of cytology and nuclear matrix protein 22 (NMP 22) for the detection and follow-up of bladder-cancer. Adv Exp Med Biol 539:111-119
4. Shariat SF, Casella R, Khoddami SM et al (2004) Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol 171:626-630
5. Botteman MF, Pashos CL, Redaelli A et al (2003) The health economics of bladder cancer: A comprehensive review of the published literature. Pharmacoeconomics 21:1315-1330
6. Gerl R, Vaux DL (2005) Apoptosis in the development and treatment of cancer. Carcinogenesis 26:263-270
7. Li F, Ling X (2006) Survivin study: An update of "what is the next wave"? J Cell Physiol 208:476-486
8. Altieri DC (2004) Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm. J Cell Biochem 92:656-663
9. Deveraux QL, Reed JC (1999) IAP family proteins - suppressors of apoptosis. Genes Dev 13:239-252
10. Caldas H, Jiang Y, Holloway MP et al (2005) Survivin splice variants regulate the balance between proliferation and cell death. Oncogene 24:1994-2007
11. Ceballos-Cancino G, Espinosa M, Maldonado V et al (2007) Regulation of mitochondrial Smac/DIABLO-selective release by survivin. Oncogene
12. Speliotes EK, Uren A, Vaux D et al (2000) The survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone. Mol Cell 6:211-223
13. Giodini A, Kallio MJ, Wall NR et al (2002) Regulation of microtubule stability and mitotic progression by survivin. Cancer Res 62:2462-2467
14. Blanc-Brude OP, Mesri M, Wall NR et al (2003) Therapeutic targeting of the survivin pathway in cancer: Initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res 9:2683-2692
15. Kawasaki H, Toyoda M, Shinohara H et al (2001) Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91:2026-2032
16. Tu SP, Jiang XH, Lin MC et al (2003) Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res 63:7724-7732
17. Smith SD, Wheeler MA, Plescia J et al (2001) Urine detection of survivin and diagnosis of bladder cancer. Jama 285:324-328
18. Weikert S, Christoph F, Schrader M et al (2005) Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Int J Cancer 116:100-104
19. Shariat SF, Ashfaq R, Roehrborn CG et al (2005) Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia. J Urol 174:2046-2050
20. Herr HW (1997) Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients. World J Urol 15:84-88
21. Schultz IJ, Kiemeney LA, Karthaus HF et al (2004) Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas. Clin Chem 50:1425-1428
22. Gazzaniga P, Gradilone A, Giuliani L et al (2003) Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 14:85-90
23. Swana HS, Grossman D, Anthony JN et al (1999) Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341:452-453
24. Ku JH, Kwak C, Lee HS et al (2004) Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. J Urol 171:631-635
25. Lehner R, Lucia MS, Jarboe EA et al (2002) Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Appl Immunohistochem Mol Morphol 10:134-138
26. Karam JA, Lotan Y, Ashfaq R et al (2007) Survivin expression in patients with non-muscle invasive urothelial cell carcinoma of the bladder. Urology (in press)
27. Hausladen DA, Wheeler MA, Altieri DC et al (2003) Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome. J Urol 170:230-234
28. Shariat SF, Karakiewicz PI, Palapattu GS et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: A contemporary series from the Bladder Cancer Research Consortium. J Urol 176:2414-2422, discussion 2422
29. Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19:666-675
30. Shariat SF, Ashfaq R, Karakiewicz PI et al (2007) Survivin expression is associated with bladder cancer presence, stage, progression, and mortality. Cancer 109:1106-1113
31. Karam JA, Lotan Y, Karakiewicz PI et al (2007) Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. Lancet Oncol 8:128-136
32. Duffy MJ, O'Donovan N, Brennan DJ et al (2007) Survivin: A promising tumor biomarker. Cancer Lett 249:49-60
33. Als AB, Dyrskjot L, von der Maase H et al (2007) Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer. Clin Cancer Res 13:4407-4414
34. Fuessel S, Herrmann J, Ning S et al (2006) Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA. Cancer Lett 232:243-254
35. Hou JQ, He J, Wang XL et al (2006) Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer. Chin Med J (Engl) 119:1734-1739
36. Ning S, Fuessel S, Kotzsch M et al (2004) siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth. Int J Oncol 25:1065-1071
37. Wang ZH, Ye Q, Huang DY et al (2007) Antisense RNA of survivin gene enhances the taxol-induced apoptosis and sensitivity to chemotherapy drugs in bladder cancer cells: An in vitro experiment. Zhonghua Yi Xue Za Zhi 87:419-422
38. Wuttig D, Kunze D, Fuessel S et al (2007) Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition? Int J Oncol 30:1317-1324
39. Altieri DC (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3:46-54
40. Wang H, Xi X, Kong X et al (2004) The expression and significance of survivin mRNA in urinary bladder carcinomas. J Cancer Res Clin Oncol 130:487-490
41. Moussa O, Abol-Enein H, Bissada NK et al (2006) Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer. J Urol 175:2312-2316
42. Kenney DM, Geschwindt RD, Kary MR et al (2007) Detection of newly diagnosed bladder cancer, bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivin. Tumour Biol 28:57-62